The Decline of Demand for COVID-19 Vaccines

Pfizer and Moderna, any company that markets a COVID-19 vaccine in the U.S., has seen revenue fall sharply. Sales of Paxilivid, their antiviral treatment for CO VID-19 fell more than 90%, which is also a big number. However, Moderna reported a smaller than expected loss on slightly better CoVID-19vaccine revenue than Wall Street had expected.